Brian Feroldi

Brian Feroldi


Brian Feroldi has been covering the healthcare and technology industries for the Motley Fool since 2015. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic. See all of his articles here and make sure you follow him on Twitter.

Recent articles

Here's Why Guess? Is Tanking Today

Shares plunge after the retailer reports fourth-quarter results that missed the mark. Here's what investors need to know.

3 Top Healthcare Stocks to Buy in March

Find out why our Motley Fool contributors called out these three businesses as top opportunities right now.

Why Cloudera Is Slumping Today

Shares of the software-as-a-service provider swoon in response to mixed quarterly results. Here are the key details for investors.

Better Buy: Amgen vs. Biogen

These cash-flow monsters are trading on the cheap. Which is the better bet for new money today?

Is DexCom a Buy?

The diabetes-focused darling has been a monster winner. Is it too late to get in?